Client Login      

Medicus International has been successfully delivering high quality medical education programmes to US, EU and Asia Pacific based global pharmaceutical and biotech clients for over 35 years. We develop inspired strategic solutions through an understanding of market opportunities and trends, product differentiation and required target audience reach. This philosophy has established us as experts in defining global communications strategies that deliver brand success.





The lifecycle of your brand

Find out more about careers with Medicus International

See the therapy areas in which have expertise

 

    Medicus International on LinkedIn 

 

 
Wilex recommends against accepting dievini Hopp offer *** AstraZeneca raises EPS guidance as Brilinta news provides welcome boost *** Sanofi-Aventis fuels Genzyme buyout rumours after Q2 income jump *** US FDA advisors back AstraZeneca's Brilinta for thrombotic events *** Australian thalidomide victims receive A$50 million compensation *** Alliance Boots raises stake in Turkish wholesaler *** Financially robust Vernalis to focus on shareholder value *** Merck KGaA's hopes for Millipore raise 2010 outlook *** NICE to reappraise Celgene's Vidaza for leukaemia following appeal *** Questions remain about Provenge, says NEJM editorial *** Antisoma losses widen in 'challenging' year *** Bayer confirms group outlook despite dropping healthcare forecast *** US FDA approves Shionogi's Cuvposa for drooling *** International formulations business drives Lupin to 21% growth *** Astellas boosts Regeneron's Q2 with $295 million deal extension *** Stronger pharma sales for Kyowa Kirin despite Japanese price cut *** <storyTitle>Chi-Med moves closer to spinning off R&D division</storyTitle> *** UK regulator sets August deadline for applications for labelling changes *** New cancer drugs fund to boost access to treatments in England *** <storyTitle>Proximagen's R&D commitment set to continue despite higher H1 loss </storyTitle> ***
Copyright 2010 by Medicus International